Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Cyclosporine in Dry Eye Syndrome
NCT00549289Phase 3Completed
- Sponsor
- Sirion Therapeutics, Inc.
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in dry eye syndrome (DED), sponsored by Sirion Therapeutics, Inc.. Status: completed.
02
Drugs
cyclosporine
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00549289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549289.